New patent for Vanda Pharms drug HETLIOZ
Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two […]
Patent Added
New patent for Mylan Ireland drug YUPELRI
Annual Drug Patent Expirations for YUPELRI Yupelri is a drug marketed by Mylan Ireland Ltd and is included in one
New patent for Axsome Malta drug SUNOSI
Annual Drug Patent Expirations for SUNOSI Sunosi is a drug marketed by Axsome Malta and is included in one NDA.
New patent for Delcath Systems drug HEPZATO
Annual Drug Patent Expirations for HEPZATO Hepzato is a drug marketed by Delcath Systems Inc and is included in one
New patent for IMPAX drug ADRENACLICK
Annual Drug Patent Expirations for ADRENACLICK Adrenaclick is a drug marketed by Impax and is included in one NDA. It
New patent for IMPAX drug TWINJECT 0.15
Annual Drug Patent Expirations for TWINJECT+0.15 Twinject 0.15 is a drug marketed by Impax and is included in one NDA.
New patent for IMPAX drug TWINJECT 0.3
Annual Drug Patent Expirations for TWINJECT+0.3 Twinject 0.3 is a drug marketed by Impax and is included in one NDA.
New patent for Purdue Pharma drug HYSINGLA ER
Annual Drug Patent Expirations for HYSINGLA+ER Hysingla Er is a drug marketed by Purdue Pharma Lp and is included in
New patent for Blueprint Medicines drug AYVAKIT
Annual Drug Patent Expirations for AYVAKIT Ayvakit is a drug marketed by Blueprint Medicines and is included in one NDA.
